Scintica’s Post

🧬 Scientists are uncovering what could be a critical breakthrough in the fight against antibiotic-resistant bacteria! 🦠 This discovery might just be the key to curbing these superbugs—how do you think it could reshape the future of medicine? 💡 Read on to learn how innovation in the lab might finally give us the upper hand. 📓https://bit.ly/4edxXGl #AntibioticResistance #FutureOfMedicine #LabDiscoveries

VRS Computed Identifiers are globally unique identifiers for genomic variants, developed by the Global Alliance for Genomics & Health. OakVar can now produce the VRS Computed Identifiers of input variants, thanks to `vrs_id` annotation module. Great work Martin Stoves! This is yet another addition to OakVar's growing support of various standards. Install it with `ov module install vrs_id`. Use it as `ov run input.vcf -a vrs_id`.

The Role of Genomics in Modern Healthcare Genomics is at the forefront of a new era in healthcare, where personalized medicine is becoming the norm. By understanding the genetic makeup of individuals, we can develop more targeted and effective treatments for a variety of diseases. At Genomac Holdings, we're leveraging the power of genomics to drive innovation in healthcare, from research to real-world applications. Our work is not just about advancing science; it's about making a tangible difference in people's lives. As we continue to explore the potential of genomics, we're excited to share our findings and collaborate with global stakeholders to push the boundaries of what's possible in healthcare. #Genomics #HealthcareInnovation #PersonalizedMedicine #Biotech #Innovation

The Power of Genomic Data in Precision Medicine Genomic data is the cornerstone of precision medicine, offering insights that enable personalized treatments. Dive into our latest article to understand the value, acquisition, and analysis of genomic data. Make informed investment decisions in this transformative field. 🧬💡 #GenomicData #PrecisionMedicine #HealthTechInvesting https://lnkd.in/g69a33Tz

📝 [PROMEGA NOTE] 𝐍𝐚𝐯𝐢𝐠𝐚𝐭𝐢𝐧𝐠 𝐈𝐧 𝐕𝐢𝐯𝐨 𝐁𝐢𝐨𝐥𝐮𝐦𝐢𝐧𝐞𝐬𝐜𝐞𝐧𝐜𝐞 𝐈𝐦𝐚𝐠𝐢𝐧𝐠: 𝐓𝐢𝐩𝐬 𝐟𝐨𝐫 𝐄𝐧𝐡𝐚𝐧𝐜𝐞𝐝 𝐒𝐮𝐜𝐜𝐞𝐬𝐬 𝐚𝐧𝐝 𝐄𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲 🔬 Optical imaging is revolutionizing the way we understand complex biological processes. By using fluorescence and bioluminescence, researchers can now observe protein behaviors, chemical reactions, and cell interactions in real time, within living organisms. 🔦 Bioluminescent Imaging (BLI) doesn't require external light, making it ideal for deep tissue observation in small animals. BLI is particularly effective for studying disease progression, drug efficacy, and viral infections non-invasively, aligning with the ethical 3Rs of animal research: Replacement, Reduction, and Refinement. 👓 Learn more about the key factors for successful 𝘪𝘯 𝘷𝘪𝘷𝘰 BLI by visiting the Promega website https://bit.ly/3QD6WDp

Technology powers our research at Calico. Kendra Nyberg leads our Microfluidics Group, where she and her team develop advanced screening technologies that enhance the precision and throughput of screens—unlocking new research possibilities that traditional methods cannot. By leveraging microfluidics, Kendra is helping us push the boundaries of what’s possible in aging science. Discover how Kendra and her colleagues at Calico are contributing to a greater understanding of aging and age-related diseases: https://lnkd.in/gG3reMZa #ExploreWithUs #ScienceCareers

#ASHG24 Day 2: All Eyes on Single-Cell Single-Cell Sequencing is becoming a more mature technology, and it seems like every industry player, big and small, in the genomics world has launched their own single-cell tools. A space once dominated by 10x Genomics is now a crowded market, and more people are talking about Parse Biosciences. Spatial Biology had some representation, but the technology needs more development and a lower price tag before we start seeing wider adoption, especially in the pathology space.

We are proud to announce that CN Bio has been featured in Business Weekly newspaper's Killer 50 list for the second year running! 🎉 Their list highlights the top 50 life science companies in the UK with the most disruptive technologies. We are honored to have our innovative PhysioMimix® Organ-on-a-chip Systems recognized once again. Our incredible team is on a mission to enable our customers to do something incredible – recreate three-dimensional human organs and tissues in the laboratory to better understand human physiology, disease, and the effectiveness of new drugs. Why? To facilitate a future where drugs are discovered more quickly, brought to patients more cost-effectively, and through the use of less animal experimentation. Discover how our PhysioMimix platform, its applications, and our contract research services support this mission at https://bit.ly/3UjYwT7. #LifeSciences #Innovation #OrganOnAChip #Killer50

🚀 Topic: 𝐂𝐑𝐈𝐒𝐏𝐑-𝐁𝐚𝐬𝐞𝐝 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐓𝐨𝐨𝐥𝐬 🔍 Precision Revolution: Transform diagnostics with CRISPR, identifying diseases with pinpoint accuracy, even before symptoms emerge! Early detection means better outcomes! 🌟 🛠️ From Lab to Clinic: These tools aren't just for the bench! They're quickly transitioning to real-world applications, detecting viruses like COVID-19 and pathogens with ease. 🦠 ⏱️ Speed & Sensitivity: CRISPR diagnostics offer rapid and sensitive results, crucial for timely and effective treatment. Say goodbye to long lab waits! ⏰ 💡 Innovation Booster: Continuous advancements are pushing boundaries, paving the way for more flexible, portable, and affordable diagnostic solutions. The future is here, folks! 🔭 For a deep dive into the latest in CRISPR tech, check out sciqst.com. They transform research into comprehensive reviews, saving you time for groundbreaking discoveries! 📚 #CRISPR #DiagnosticRevolution #MedicalInnovation #Biotech #SciQst

Discover how the Bayh-Dole Act transformed scientific research into real-world solutions in our latest article featured on our new Substack page, 'This Genomic Life.' Learn about the pivotal role of technology transfer in bridging academia and industry. #Substack #technology #biotech